BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2025 7:59:27 AM | Browse: 103 | Download: 562
 |
Received |
|
2024-07-04 22:33 |
|
Peer-Review Started |
|
2024-07-04 22:33 |
|
First Decision by Editorial Office Director |
|
2024-10-11 09:42 |
|
Return for Revision |
|
2024-10-11 09:42 |
|
Revised |
|
2024-10-24 04:55 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-12-17 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-17 08:20 |
|
Articles in Press |
|
2024-12-17 08:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-01-02 01:19 |
|
Publish the Manuscript Online |
|
2025-01-07 07:59 |
| ISSN |
2307-8960 (online) |
| Open Access |
The first time an abbreviation appears in the manuscript, please label it with its full name. |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Corticosteroids in posterior reversible encephalopathy syndrome: Friend or foe? A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Bahadar S Srichawla, Taranjit Kaur and Harsimran Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bahadar S Srichawla, Consultant, MS, Staff Physician, Department of Neurology, University of Massachusetts Chan Medical School, 55 Lake Ave N, Worcester, MA 01655, United States. bahadar.srichawla@umassmed.edu |
| Key Words |
Corticosteroids; Posterior reversible encephalopathy syndrome; Vasogenic edema; Reversible posterior leukoencephalopathy syndrome; Reversible cerebral vasoconstriction syndrome |
| Core Tip |
Posterior reversible encephalopathy syndrome (PRES) is characterized by headaches, seizures, confusion, and visual disturbances due to endothelial dysfunction and vasogenic edema. Corticosteroids have a dual role in PRES, potentially inducing the condition through hypertension while also treating it by reducing inflammation and stabilizing the blood-brain barrier. This systematic review identifies 57 cases of corticosteroid-induced PRES and 14 cases where corticosteroids were used therapeutically. Understanding this dual role is crucial for optimizing patient care, highlighting the need for careful monitoring and tailored treatment strategies. |
| Publish Date |
2025-01-07 07:59 |
| Citation |
Srichawla BS, Kaur T, Singh H. Corticosteroids in posterior reversible encephalopathy syndrome: Friend or foe? A systematic review. World J Clin Cases 2025; 13(12): 98768 |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i12/98768.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i12.98768 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
